Assessment of Glial Scar, Tissue Sparing, Behavioral Recovery and Axonal Regeneration following Acute Transplantation of Genetically Modified Human Umbilical Cord Blood Cells in a Rat Model of Spinal Cord Contusion
Yana O Mukhamedshina, Ekaterina E Garanina, Galina A Masgutova, Luisa R Galieva, Elvira R Sanatova, Yurii A Chelyshev, Albert A Rizvanov, Yana O Mukhamedshina, Ekaterina E Garanina, Galina A Masgutova, Luisa R Galieva, Elvira R Sanatova, Yurii A Chelyshev, Albert A Rizvanov
Abstract
Objective and methods: This study investigated the potential for protective effects of human umbilical cord blood mononuclear cells (UCB-MCs) genetically modified with the VEGF and GNDF genes on contusion spinal cord injury (SCI) in rats. An adenoviral vector was constructed for targeted delivery of VEGF and GDNF to UCB-MCs. Using a rat contusion SCI model we examined the efficacy of the construct on tissue sparing, glial scar severity, the extent of axonal regeneration, recovery of motor function, and analyzed the expression of the recombinant genes VEGF and GNDF in vitro and in vivo.
Results: Transplantation of UCB-MCs transduced with adenoviral vectors expressing VEGF and GDNF at the site of SCI induced tissue sparing, behavioral recovery and axonal regeneration comparing to the other constructs tested. The adenovirus encoding VEGF and GDNF for transduction of UCB-MCs was shown to be an effective and stable vehicle for these cells in vivo following the transplantation into the contused spinal cord.
Conclusion: Our results show that a gene delivery using UCB-MCs-expressing VEGF and GNDF genes improved both structural and functional parameters after SCI. Further histological and behavioral studies, especially at later time points, in animals with SCI after transplantation of genetically modified UCB-MCs (overexpressing VEGF and GDNF genes) will provide additional insight into therapeutic potential of such cells.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Kuh SU, Cho YE, Yoon DH, Kim KN, Ha Y. Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat. Acta Neurochirurgica (Wien). 2005;147(9): 985–992.
- Yan HB, Zhang ZM, Jin DD, Wang XJ, Lu KW. The repair of acute spinal cord injury in rats by olfactory ensheathing cells graft modified by glia cell line–derived neurotrophic factor gene in combination with the injection of monoclonal antibody IN–1. Zhonghua Wai Ke Za Zhi. 2009;47(23): 1817–1820.
- Kim HM, Hwang DH, Lee JE, Kim SU, Kim BG. Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury. PLoS One. 2009;4(3): 1–10.
- Lin WP, Chen XW, Zhang LQ, Wu CY, Huang ZD, Lin JH.Effect of neuroglobin genetically modified bone marrow mesenchymal stem cells transplantation on spinal cord injury in rabbits. PLoS One. 2013;8(5): 1–9.
- Jones LL, Oudega M, Bunge MB, Tuszynski MH. Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury. J Physiol. 2001;533(1): 83–89.
- Gluckman E, Locatelli F. Umbilical cord blood transplants. Opin Hematol. 2000;7(6): 353–357.
- Weiss M, Troyer D. Stem cells in the umbilical cord. Stem Cell Rev. 2007;2: 155–162.
- Park SI, Lim JY, Jeong CH, Kim SM, Jun JA, Jeun SS, et al. Human umbilical cord blood-derived mesenchymal stem cell therapy promotes functional recovery of contused rat spinal cord through enhancement of endogenous cell proliferation and oligogenesis. J Biomed Biotechnol. 2012: 1–8.
- Rodrigues LP, Iglesias D, Nicola FC, Steffens D, Valentim L, Witczak A, et al. Transplantation of mononuclear cells from human umbilical cord blood promotes functional recovery after traumatic spinal cord injury in Wistar rats. Braz J Med Biol Res. 2012;45(1): 49–57.
- Mukhamedshina YO, Shaymardanova GF, Garanina EE, Salafutdinov II, Rizvanov AA, Islamov RR, et al. Adenoviral vector carrying glial cell-derived neurotrophic factor for direct gene therapy or human umbilical cord blood cell-mediated therapy of spinal cord injury in rat. Spinal Cord. 2015. September 29 10.1038/sc.2015.161 [Epub ahead of print]
- Ikeda YN, Fukuda M, Wada T, Matsumoto A, Satomi S, Yokoyama S, et al. Development of angiogenic cell and gene therapy by transplantation of umbilical cord blood with vascular endothelial growth factor gene. Hypertens Res. 2004;27(2): 119–128.
- Cheng H, Wu JP, Tzeng SF. Neuroprotection of glial cell line–derived neurotrophic factor in damaged spinal cords following contusive injury. Neurosci Res. 2002;69(3): 397–405.
- Islamov RR, Chintalgattu V, Pak ES. Induction of VEGF and its Flt-1 receptor after sciatic nerve crush injury. Neuroreport. 2004;15(13): 2117–2121.
- Mackenzie F, MacRuhrberg C. Diverse roles for VEGF–A in the nervous system. Development. 2012;139(8): 1371–1380. 10.1242/dev.072348
- Rosenstein JM, Mani N, Silverman WF, Krum JM. Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc Natl Acad Sci USA. 1998;95(12): 7086–7091.
- Jin H, Liu ML, Kim HA, Lee M, An S, Oh J, et al. Role of the oxygen–dependent degradation domain in a hypoxia–inducible gene expression system in vascular endothelial growth factor gene therapy. Spine. 2009;34(26): 952–958.
- Sondell M, Sundler F, Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk–1 receptor. Eur J Neurosci. 2004;12: 4243–4254.
- Mills CD, Allchorne AJ, Griffin RS, Woolf CJ, Costigan M. GDNF selectively promotes regeneration of injury–primed sensory neurons in the lesioned spinal cord. Mol Cell Neurosci.2007;36(2): 185–194.
- Islamov RR, Rizvanov AA, Mukhamedyarov MA, Salafutdinov II, Garanina EE, Fedotova VY, et al. Symptomatic Improvement, Increased Life-Span and Sustained Cell Homing in Amyotrophic Lateral Sclerosis After Transplantation of Human Umbilical Cord Blood Cells Genetically Modified with Adeno-Viral Vectors Expressing a Neuro-Protective Factor and a Neural Cell Adhesion Molecule. Curr Gene Ther. 2015;15(3): 266–276.
- Lebedev SV, Timofeyev SV, Zharkov AV, Schipilov VG, Chelyshev JA, Masgutova GA, et al. Exercise tests and BBB method for evaluation of motor disorders in rats after contusion spinal injury. Bull Exp Biol Med. 2008;146(4): 489–494.
- Mukhamedshina YO, Shaymardanova GF, Muhitov AR, Salafutdinov II, Rizvanov AA, Zarubina VN, et al. Survival and differentiation of endogenous Schwann cells migrating into spinal cord under the influence of neurotrophic factors. Cellular Transplantation and Tissue Engineering. 2012;7(3): 125–129.
- Barbour HR, Plant CD, Harvey AR, Plant GW. Tissue sparing, behavioral recovery, supraspinal axonal sparing/regeneration following sub-acute glial transplantation in a model of spinal cord contusion. BMC Neurosci. 2013. September 27;14:106 10.1186/1471-2202-14-106
- Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 1995;12(1): 1–21.
- Zhang L, Ma Z, Smith GM, Wen X, Pressman Y, et al. GDNF-enhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons. Glia. 2009;57(11): 1178–1191. 10.1002/glia.20840
- Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. Neurosci. 1999;19(14): 5731–5740.
- Deng LX, Hu J, Liu N, Wang X, Smith GM, Wen X, et al. GDNF modifies reactive astrogliosis allowing robust axonal regeneration through Schwann cell-seeded guidance channels after spinal cord injury. Exp Neurol. 2011;229(2): 238–250. 10.1016/j.expneurol.2011.02.001
- Lutton C, Young YW, Williams R, Meedeniya AC, Mackay-Sim A, Goss B. Combined VEGF and PDGF treatment reduces secondary degeneration after spinal cord injury. J Neurotrauma. 2012;29(5): 957–970. 10.1089/neu.2010.1423
- Antonic A, Sena ES, Lees JS, Wills TE, Skeers P, Batchelor PE, et al. Stem cell transplantation in traumatic spinal cord injury: a systematic review and meta-analysis of animal studies. PLoS Biol. 2013;11(12): 1–14.
Source: PubMed